Results 291 to 300 of about 371,827 (350)

Failing Forward in Peripheral T-Cell Lymphoma. [PDF]

J Clin Oncol
Mehta-Shah N, Horwitz SM.
europepmc   +1 more source

Multiple Successful Desensitizations to Brentuximab Vedotin in the Setting of Relapsed Peripheral T-Cell Lymphoma: Case Report. [PDF]

Can J Hosp Pharm
Rashid AR, Kuruvilla P.
europepmc   +1 more source

Molecular heterogeneity of CD30⁺ peripheral T-cell lymphoma with prognostic significance and therapeutic implications: a retrospective multi-centre study. [PDF]

EBioMedicine
Huo YJ, Cheng S, Yi HM, Niu T, Fan L, Cui GH, Zhou FL, Song XM, Li F, Bai O, Yan XJ, Shi J, Cai MC, Huang YH, Dong L, Xiong J, Hu S, Qiu YR, Zhao Y, Xu PP, Wang L, Lu M, Jing HM, Zhao WL.   +23 more
europepmc   +1 more source

The outcome of patients with peripheral T cell lymphoma treated with doxorubicin-based (CHOP) and pirarubicin-based regimen (THP-COP) regimen: a single institution experience. [PDF]

J Clin Exp Hematop
Iriyama N, Miura K, Takahashi H, Nakagawa M, Iizuka K, Otake S, Hamada T, Koike T, Kurihara K, Endo T, Nakamura H.   +10 more
europepmc   +1 more source

A multicenter, open-label, single-arm, phase Ib clinical trial of HH2853 treatment in patients with relapsed and/or refractory peripheral T-cell lymphoma. [PDF]

J Hematol Oncol
Hong H, Chen Z, Zhang M, Peng Z, Shen J, Shuang Y, Zhou H, Guo H, Huang H, Li F, Qian Z, Liu L, Wang L, Yang W, Zhang L, He P, Qian S, Li F, Li M, Lin T.   +19 more
europepmc   +1 more source

Peripheral T-Cell Lymphoma, Not Otherwise Specified, Diagnosed from Prostate Tissue: A Rare Case [PDF]

Turk J Haematol
Çiftçiler R, Önner H, Selim C.
europepmc   +1 more source

ALK Expression in Nerve Sheath Myxoma: A Potential Diagnostic Pitfall

Journal of Cutaneous Pathology, EarlyView.
Daniel Cole, May P. Chan, Douglas Rottmann, Bryan L. Betz, Noah Brown, Venezia Podesta, Paul W. Harms   +6 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Peripheral T‐cell lymphomas

Hematological Oncology, 2023
AbstractThe treatment of peripheral T‐cell lymphomas is challenging, as they often display a severe prognosis and lack effective treatment strategies. We will try to answer three burning questions: can we differentiate the initial treatment based on the histotype and the clinical presentation of peripheral T‐cell lymphoma patients?
Broccoli A., Zinzani P. L.
openaire   +3 more sources

Peripheral T-cell lymphoma

Cancer and Metastasis Reviews, 1988
Since the discovery of human T-cell leukemia virus type 1 (HTLV-1) in patients with adult T-cell leukemia/lymphoma (ATLL), malignant neoplasms of mature (peripheral) T lymphocytes have attracted a great deal of attention. This type of neoplasm is more common in Japan than in Western countries, and may show distinct clinical pictures such as ...
S, Watanabe, K, Mukai, M, Shimoyama
openaire   +2 more sources

Peripheral T-Cell Lymphoma

Hematology/Oncology Clinics of North America, 2019
Non-anaplastic peripheral T-cell lymphoma (PTCL) is a heterogenous group of disorders comprising about 1% of non-Hodgkin lymphoma (NHL) in children and adolescents. Most common subtypes are peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) followed by NK−/T-cell lymphoma (NKTCL), hepatosplenic T-cell lymphoma (HSTCL), and subcutaneous ...
Samuel Y. Ng, Eric D. Jacobsen
openaire   +2 more sources